Fujirebio is an R&D-driven multinational biotechnology company constantly developing new technologies and unique biomarkers with high clinical value. Fujirebio mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Fujirebio is founded and headquartered in Tokyo, Japan, and present locally with offices in Japan, Asia, Europe and the United States and through a large international distribution network. The company has manufacturing facilities in Japan, Europe and the United States.